Showing results (811-820 of 914) with videos related to
Sort By:
Pageof 92
Sleep|January 30, 2024
Suvorexant alters dynamics of the sleep-electroencephalography-power spectrum and depressive-symptom trajectories during inpatient opioid withdrawalMatthew J Reid, Kelly E Dunn, Liza Abraham, et al.Substance Abuse|June 3, 2022
Need for clarity and context in case reports on kratom use, assessment, and interventionKirsten E Smith, Kelly E Dunn, David H Epstein, et al.Biochemistry|April 14, 2016
Synergistic Biomineralization Phenomena Created by a Combinatorial Nacre Protein Model SystemEric P Chang, Teresa Roncal-Herrero, Tamara Morgan, et al.Drug and Alcohol Dependence|September 5, 2025
Craving for opioid and cannabis use among adults with chronic pain: Insights from a 30-day ecological momentary assessment studyJennifer D Ellis, Ashley E Chipoletti, Siny Tsang, et al.Journal of the American College of Cardiology|July 11, 2020
Characteristics of Adults With Congenital Heart Defects in the United StatesMichelle Gurvitz, Julie E Dunn, Ami Bhatt, et al.Stem Cells (Dayton, Ohio)|March 15, 2012
Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in miceCathy Lee, Abbas Fotovati, Joanna Triscott, et al.Biochemistry|December 24, 1996
Protein engineering thrombin for optimal specificity and potency of anticoagulant activity in vivoM Tsiang, L R Paborsky, W X Li, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 11, 2019
Cancer survivor perspectives on sharing patient-generated health data with central cancer registriesT G Smith, M E Dunn, K Y Levin, et al.Biorxiv : the Preprint Server for Biology|March 10, 2025
Evidence for Functional Regulation of the KLHL3/WNK Pathway by O-GlcNAcylationJimin Hu, Duc T Huynh, Denise E Dunn, et al.Molecular Pharmacology|June 28, 2007
The phosphoinositide-dependent kinase-1 inhibitor 2-amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) prevents Y-box binding protein-1 from inducing epidermal growth factor receptorK To, Y Zhao, H Jiang, et al.Pageof 92